Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
|Videos|July 19, 2017
How Can Pharmacists Promote the Value of the Profession?
Lucinda Maine, Phd, RPh, Executive Vice President and CEO of the American Association of Colleges of Pharmacy (AACP), discusses how pharmacists can promote the value of the profession to their patients and the public.
Advertisement
Lucinda Maine, Phd, RPh, Executive Vice President and CEO of the American Association of Colleges of Pharmacy (AACP), discusses how pharmacists can promote the value of the profession to their patients and the public.
Advertisement
Related to this article
Phase 3 TRIUMPH-2 data presented at EASD show HbA1c reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
In a FINE-HEART analysis, cancer history raised the risk of death and hospitalization but did not blunt finerenone's cardiovascular and kidney benefits.
Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
Marie-Claire Seeley, PhD, MNurs, RN, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity
2
Intensive Chemotherapy in Combination With Quizartinib Versus Midostaurin for FLT3-ITD Mutated Acute Myeloid Leukemia: A Multicenter Cohort Study
3
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Orforglipron Edges Oral Semaglutide 25 mg in T2D, Indirect Comparison Finds
5